These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2110011)

  • 1. Metabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: distribution of parent drug and ten metabolites obtained from control and schistosome-infected mouse urine.
    Ali MH; Abramson FP; Fetterolf DD; Cohn VH
    Biomed Environ Mass Spectrom; 1990 Mar; 19(3):186-90. PubMed ID: 2110011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism studies of the antischistosomal drug praziquantel using tandem mass spectrometry: qualitative identification of 17 hydroxylated metabolites from mouse urine.
    Ali MH; Fetterolf DD; Abramson FP; Cohn VH
    Biomed Environ Mass Spectrom; 1990 Mar; 19(3):179-85. PubMed ID: 2110010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
    Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
    Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Profiling of
    Rosenberger L; Jenniches J; von Essen C; Khutia A; Kühn C; Marx A; Georgi K; Hirsch AKH; Hartmann RW; Badolo L
    Drug Metab Dispos; 2022 Apr; 50(4):320-326. PubMed ID: 35115299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of praziquantel enantiomers.
    Wang H; Fang ZZ; Zheng Y; Zhou K; Hu C; Krausz KW; Sun D; Idle JR; Gonzalez FJ
    Biochem Pharmacol; 2014 Jul; 90(2):166-78. PubMed ID: 24821110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
    Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
    Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
    Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
    Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
    Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
    Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
    APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and identification of 8-hydroxypraziquantel as a metabolite of the antischistosomal drug praziquantel.
    Schepmann D; Blaschke G
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):791-9. PubMed ID: 11600290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
    El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
    Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and bioavailability of different praziquantel brands.
    Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
    Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetic evaluation of praziquantel loaded in poly (methyl methacrylate) nanoparticle using a HPLC-MS/MS.
    Malhado M; Pinto DP; Silva AC; Silveira GP; Pereira HM; Santos JG; Guilarducci-Ferraz CV; Viçosa AL; Nele M; Fonseca LB; Pinto JC; Calil-Elias S
    J Pharm Biomed Anal; 2016 Jan; 117():405-12. PubMed ID: 26440288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
    Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
    Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
    Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
    Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
    el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
    Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
    Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI
    Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.